COR vs K · P/E 21, rev $321.33B vs P/E 23, $29.03B cap
Cencora Inc. (COR) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Kellanova (K) is a packaged foods company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
K does not have a complete income-statement cache yet.
COR currently screens at market cap $53.91B and trailing P/E 21.2. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the COR and K stock pages for the full models.
Not investment advice.